BALYASNY ASSET MANAGEMENT L.P.

Q2 2025 13F-HR Detailed Holdings

Location
Chicago, IL
Holdings as of
6/30/2025
Date filed
8/14/2025
Form type
13F-HR
Num holdings
2,740
Total value ($000)
$66,411,789
Net value change ($000)
+5,927,142 (9.8%)
New positions
603
Sold out positions
621
Turnover %
28.7%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BRO 493,548 86284.6%
ANET 373,122 NEW
NVDA 335,654 75.2%
AVGO 290,191 474.0%
UNP 280,563 1393.8%
CMG 264,801 7985.6%
LLY 264,797 210.7%
ORCL 253,453 2283.8%
AJG 245,979 38434.2%
ABBV 234,341 4032.7%
Top Reduces (Value $000, Stocks/ETFs)
IVV -481,277 -93.8%
VTI -369,490 -100.0%
SPY -353,013 -55.3%
SCHW -351,139 -84.7%
MA -337,570 -81.6%
DFS -300,240 -100.0%
Intra-Cellular Therapies, Inc. -297,864 -100.0%
WFC -287,556 -82.1%
MCHP -231,264 -99.3%
DHR -228,980 -96.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 22,382,475 (33.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None